However, excessive IL-17 production has been implicated in chronic inflammatory processes, contributing to tissue damage and various autoimmune disorders, including psoriasis, spondyloarthropathies, rheumatoid arthritis, and multiple sclerosis (8). This evidence concerns the gene IL17A and psoriasis.